Cegedim SA (EPA:ALCGM)
11.42
+0.02 (0.18%)
Jun 3, 2026, 5:35 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €156.81 million as of June 3, 2026. Its market cap has increased by 0.30% in one year.
Market Cap
156.81M
Enterprise Value
406.11M
Revenue
649.17M
Ranking
n/a
PE Ratio
16.71
Stock Price
€11.42
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 156.81M, an increase of 37.73%. That is a compound annual growth rate of 1.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 156.53M | -16.10% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 89.01B |
| EssilorLuxottica Société anonyme | 79.44B |
| Sartorius Stedim Biotech | 17.27B |
| Ipsen | 12.46B |
| Carvolix | 217.42M |
| Median Technologies | 215.09M |
| Bastide Le Confort Médical | 187.53M |
| Innate Pharma | 148.63M |